The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
comorbidity and its impact on 1,590 patients with Koba 19 in China a nationwide analysis... 25.1% reported having at least one comorbidity, which included hypertension cardiovascular disease cerebral vascular diseases diabetes hepatitis B chronic obstructive pulmonary disease chronic kidney diseases malignancy and immunodeficiency okay 8.2 percent reported having two or more comorbidities
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.